SCHEMBL25425918

SCHEMBL25425918

Fc1cc2c(CC(F)F)cn(C3CCC3)c2nc1Cl

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 7/20 0.35
▸ TOP2B Q02880 7/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25888058 0.85 TOP2A (0.36) TOP2ATOP2B
SCHEMBL25888068 0.79 TOP2A (0.33) TOP2ATOP2B
SCHEMBL25427194 0.77 LRRK2 (0.31) —
SCHEMBL30510510 0.77 LRRK2 (0.31) —
SCHEMBL25427196 0.77 LRRK2 (0.31) —
SCHEMBL25888052 0.77 TOP2A (0.34) TOP2ATOP2B
SCHEMBL25427926 0.76 DPP4 (0.37) TOP2ATOP2B
SCHEMBL30510604 0.76 DPP4 (0.37) TOP2ATOP2B
SCHEMBL30510577 0.73 PIK3CG (0.31) —
SCHEMBL25424714 0.73 PIK3CG (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122093-A1 REV-ERB AGONISTS FOR TH17-MEDIATED INFLAMMATORY DISORDERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-06-29 — — WO disclosed
Send feedback